ICON plc is a global clinical research organization (CRO) that provides consulting, clinical development, and commercialization services to the pharmaceutical industry. Founded by John Climax and Ronan Lambe in 1990, ICON has grown significantly, employing approximately 41,900 employees across 106 locations in 55 countries as of February 2025. The company is listed on the Nasdaq stock exchange and has a strong presence in multiple therapeutic areas. ICON focuses on reducing time to market, cost reduction, and quality enhancement for its clients. It has made several strategic acquisitions to expand its capabilities and market reach. ICON is recognized as a leading CRO and has received numerous industry awards for its excellence in clinical research. The company also emphasizes innovation, community engagement, and exceeding quality standards expected by clients and regulatory bodies.